50 related articles for article (PubMed ID: 38752755)
1. Multidisciplinary Approach to Patent Foramen Ovale Closure for Cryptogenic Stroke: Brain-Heart Board Experience.
Khan M; Miller M; Mccarthy P; Tsai JP; Merhi W; Berkompas D; Wees N; Khan NI; Ahrar A; Evans E; Dahu M; Gauri A; Moelker T; Chalfoun N; Min J
Neurol Clin Pract; 2024 Aug; 14(4):e200319. PubMed ID: 38826798
[TBL] [Abstract][Full Text] [Related]
2. Patent Foramen Ovale Occlusion in Elderly Patients: Is It Worth It? A Large, Single-Center Retrospective Analysis.
Gili S; Calligaris G; Teruzzi G; Santagostino Baldi G; Muratori M; Montorsi P; Trabattoni D
J Clin Med; 2024 Jun; 13(12):. PubMed ID: 38930044
[No Abstract] [Full Text] [Related]
3. Updates on Patent Foramen Ovale (PFO) Closure.
Voudris KV; Poulin MF; Kavinsky CJ
Curr Cardiol Rep; 2024 Jun; ():. PubMed ID: 38913234
[TBL] [Abstract][Full Text] [Related]
4. Patent Foramen Ovale in Children: A Review of Recent Progress.
Zhang T; Gao C; Chen W; Ma H; Tao L
Pediatr Cardiol; 2024 Jun; ():. PubMed ID: 38822852
[TBL] [Abstract][Full Text] [Related]
5. A minimum specification dataset for liquid ocular endotamponades: recommendations by a European expert panel.
Ferrara M; Steel DH; Romano MR;
Graefes Arch Clin Exp Ophthalmol; 2024 Apr; 262(4):1141-1149. PubMed ID: 38038728
[TBL] [Abstract][Full Text] [Related]
6. Patent foramen ovale and stroke.
Miranda B; Fonseca AC; Ferro JM
J Neurol; 2018 Aug; 265(8):1943-1949. PubMed ID: 29680895
[TBL] [Abstract][Full Text] [Related]
7. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
[TBL] [Abstract][Full Text] [Related]
8. Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence.
Mir H; Siemieniuk RAC; Ge L; Foroutan F; Fralick M; Syed T; Lopes LC; Kuijpers T; Mas JL; Vandvik PO; Agoritsas T; Guyatt GH
BMJ Open; 2018 Jul; 8(7):e023761. PubMed ID: 30049703
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter closure of patent foramen ovale to prevent stroke recurrence in patients with otherwise unexplained ischaemic stroke: Expert consensus of the French Neurovascular Society and the French Society of Cardiology.
Mas JL; Derex L; Guérin P; Guillon B; Habib G; Juliard JM; Marijon E; Massardier E; Meneveau N; Vuillier F
Arch Cardiovasc Dis; 2019; 112(8-9):532-542. PubMed ID: 31378692
[TBL] [Abstract][Full Text] [Related]
10. Reprint of : Transcatheter closure of patent foramen ovale to prevent stroke recurrence in patients with otherwise unexplained ischaemic stroke: Expert consensus of the French Neurovascular Society and the French Society of Cardiology.
Mas JL; Derex L; Guérin P; Guillon B; Habib G; Juliard JM; Marijon E; Massardier E; Meneveau N; Vuillier F
Rev Neurol (Paris); 2020; 176(1-2):53-61. PubMed ID: 31787326
[TBL] [Abstract][Full Text] [Related]
11. European Stroke Organisation (ESO) Guidelines on the diagnosis and management of patent foramen ovale (PFO) after stroke.
Caso V; Turc G; Abdul-Rahim AH; Castro P; Hussain S; Lal A; Mattle H; Korompoki E; Søndergaard L; Toni D; Walter S; Pristipino C
Eur Stroke J; 2024 May; ():23969873241247978. PubMed ID: 38752755
[TBL] [Abstract][Full Text] [Related]
12. Patent foramen ovale closure in the management of cryptogenic stroke: a review of current literature and guideline statements.
Elzanaty AM; Patel N; Sabbagh E; Eltahawy EA
Curr Med Res Opin; 2021 Mar; 37(3):377-384. PubMed ID: 33460329
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
